fda warning letter glp-1 october 2025 letters compounding Pharmacovigilance Assessment of Compounded GLP-1 Receptor Agonists: Insights From the FDA Adverse FDA unleashes warning letters to – News Archives – Partnership for

By restoring endogenous insulin response in T2DM, they may stabilize or prevent disease progression

Some research into GLP-1 receptor agonists has suggested potential neuroprotective effects and possible benefits for certain neuropsychiatric conditions, though this research is in early stages and not specific to bipolar disorder

The role of NCOA4-mediated ferritinophagy in health and disease

Hussain A, Saikia V, Ramteke A (2012) Nitric oxide and modulatory effects of the root extracts of Phlogacanthus tubiflorus against oxidative stress induced by hydrogen peroxide

Many studies to date have had a small sample size, meaning that very few people took part in the research